Europe
vasopharm GmbH, a private biopharmaceutical company developing a novel treatment for traumatic brain injury, announced the successful completion of a €9.5 million financing co-led by HeidelbergCapital Private Equity and EF Investments.
Turning away from “low-value” (waste, overuse) towards “high-value” health care is critical for the sustainability of solidarity-based healthcare systems. The Ludwig Boltzmann Institute for Health Technology Assessment is represented on the European Expert Panel.
BioArctic received MEUR 15 milestone payment from Eisai for start of BAN2401 confirmatory Phase 3 study in early Alzheimer’s disease
Allergy Therapeutics plc provides a trading update for the year ended 30 June 2019 ahead of its Preliminary Results to be announced on 25 September 2019.
Heidelberg Pharma AG published its financial report on the first six months of 2019
Biotech and pharma companies strengthen their leadership teams with new appointments.
The World Health Organization developed a five-year plan to promote regulatory collaboration and reliance around the world and to assist national regulatory authorities in solving related issues.
Reckitt Benckiser spun Indivior off into a standalone company in 2014. Earlier this year the Department of Justice charged Indivior for its role in the opioid crisis.
iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced consistent 18-month results of the first-in-human, micro-invasive glaucoma surgery STAR-I trial for the MINIject™ device in a standalone setting.
Start Codon, a new model of life science and healthcare business accelerator, announced two appointments to its senior team.
PRESS RELEASES